| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |